TEL: +86 18320996515 I-IMEYILI:info@sunglor-led.com
Ukwelashwa kobuso ngokukhanya okubomvu kusebenzisa ubude bamaza okukhanya okuqondiwe ngaphakathi kwe-spectra ebomvu (630-670nm) kanye ne-near-infrared (810-850nm) ukuze kulethwe izinzuzo zesikhumba ezifundwe ngomtholampilo. Indlela eyisisekelo, eyaziwa ngokuthi i-photobiomodulation, ihilela ukumuncwa kwama-photon yi-mitochondrial chromophores, ikakhulukazi i-cytochrome c oxidase. Lokhu kusebenzisana kuvuselela i-metabolism yamaseli, okuholela ekukhiqizweni kwe-adenosine triphosphate (ATP) okuthuthukisiwe, ukuguqulwa kwezinhlobo ze-oxygen ezisebenzayo, kanye nokusebenza kwezindlela zokubonisana kwamaseli. Ukuqhuma okulandelayo kwezinto eziphilayo kukhuthaza ukwanda kwe-fibroblast futhi kwandisa ukwakheka kwe-collagen ne-elastin. Ukuze uthole imiphumela ebonakalayo, ukusetshenziswa njalo kwedivayisi ekhipha ubude bamaza okwelapha obuqinisekisiwe ngokukhanya okwanele akunakuxoxiswana ngakho, njengoba impendulo yezinto eziphilayo incike kumthamo wamandla we-photon olethwayo. Le ndlela ivumela ukusetshenziswa okuhlelekile, lapho ukukhanya okubomvu kugxile ekuvuseleleni i-epidermal engaphezulu kanye nokukhanya okucishe kube yi-infrared kungena ezingqimbeni zesikhumba kanye nezingaphansi kwesikhumba ukuze kuncishiswe ukuvuvukala futhi kusekelwe ukulungiswa kwezicubu, ngaleyo ndlela kuzibeka njengengxenye ebalulekile yohlelo lokunakekelwa kwesikhumba oluphelele nolwesikhathi eside.
Ukuvumelana phakathi kocwaningo lwezokwelapha kanye nochwepheshe besikhumba kuqinisekisa ukuthi ukusebenza kahle akusikho okuhlobene nobuchwepheshe uqobo kodwa kuncike kumingcele ethile, eqinisekisiwe. Imiphumela yokwelapha ihlobene ngqo namadivayisi akhipha ubude be-wavelength obuqondile ngokuvamile obungu-660 nm obomvu kanye no-850 nm wokukhanya okuseduze kwe-infrared futhi angaletha ukukhanya okwanele (umthamo wamandla endaweni ngayinye), kubalwa kusukela ekukhanyeni (ubuningi bamandla) kanye nesikhathi sokuchayeka. Iphuzu elibalulekile lokuqapha kochwepheshe ukuntuleka okuvame kakhulu kwezifundo eziqinile nezizimele zesikhathi eside kumadivayisi ebanga labathengi, kanye nezilingo eziningi ezikhona ekhaya ezixhaswe embonini futhi ezingalinganiswanga nokwelashwa okujwayelekile. Ngenxa yalokho, odokotela besikhumba beluleka abathengi ukuthi babeke phambili amadivayisi ane-FDA-clearance yezinkomba ezithile zesikhumba, isinyathelo sokulawula esidinga ukuhanjiswa kwedatha yokusebenza, kanye nokufuna lawo anemininingwane yokukhishwa ecacile, eqinisekiswe yinkampani yangaphandle ukuqinisekisa ukuvumelana nesayensi ye-photobiomodulation esunguliwe.
Isinyathelo esibalulekile kodwa esivame ukunganakwa sokwamukela ukwelashwa kokukhanya okubomvu ekhaya ukuhlolwa kokuphepha okuphelele. Ingozi eyinhloko ihilela ukuzwela kwe-photosensitivity, okungabangelwa yimithi ehlukahlukene yesistimu (isb., ama-antibiotic e-tetracycline, ama-diuretics, ama-antihistamine athile) kanye nezithako zangaphandle (kufaka phakathi ama-retinoids, ama-AHA, nama-BHA). Le ngozi ikhuliswa ukungabikho okuvamile kokuhlolwa kwangaphambi kokwelashwa okuqondiswa udokotela ohambweni lokuthenga kwabathengi. Ngaphezu kwalokho, ukusetshenziswa okuphephile nokusebenzayo kwala madivayisi kudlulela ngale kokuhlolwa kokuqala kokungavunyelwa; kudinga ukuqonda imvamisa yokwelashwa efanele, ubude, kanye nezilinganiso eziqongelelekayo ezivame ukuchazwa ngokungacacile kumsebenzisi wasekhaya. Ukuzulazula kuleli gebe phakathi kwezinqubo zomtholampilo ezilawulwayo nokusetshenziswa okungaqondiswanga kuyisici esibalulekile sobunikazi bedivayisi obunomthwalo wemfanelo.
Ukwahlukana phakathi kwamadivayisi okwelapha ngokukhanya okubomvu ochwepheshe nasekhaya kuchazwa okungaphezu nje kokuqina kokukhipha; kuhlanganisa ukulinganisa, ukuhambisana, kanye nokuqinisekiswa kwezokwelapha. Izinhlelo zobungcweti zenzelwe ukuletha imithamo eqondile, ephindaphindwayo ngaphansi kokuqashwa kwezokwelapha, okuvumela ukwelashwa okuqondisiwe kwezimo ezithile. Ngokuphambene nalokho, imakethe yabathengi igcwele amadivayisi asebenza ngaphansi kokubhekwa okuqinile, lapho izimangalo zokumaketha mayelana namandla nokusebenza kahle kungase kungabi nokuqinisekiswa kwedatha eqinisekisiwe ngokuzimela. Indlela ehlakaniphile kakhulu ibheka la mathuluzi njengokuhambisanayo: ukwelashwa kochwepheshe kunikeza ukungenelela okunamandla aphezulu, okunolwazi ngokuxilonga, kuyilapho idivayisi ekhethwe kahle ekhaya ehlolwe ngezincazelo zayo zokukhipha ezicacile kanye neziqondiso zokusebenzisa ezicacile isebenza njengendlela ephumelelayo yokugcinwa okuqhubekayo, yakha ukuqhubeka kokunakekelwa okuhlangene.
Beka phambili uhlu lokuhlola olulandelayo ukuze uzulazule emakethe ngempumelelo:
Iyini indlela eyinhloko yesayensi yokwelapha ubuso ngokukhanya okubomvu?
Ukwelashwa kobuso okukhanyayo okubomvu kusebenza ngenqubo ebizwa ngokuthi i-photobiomodulation. Amaza athile okukhanya okubomvu (630-670nm) kanye nokukhanya okuseduze kwe-infrared (810-850nm) amuncwa yizingxenye ezisemaselini ethu, ikakhulukazi i-enzyme ebizwa ngokuthi i-cytochrome c oxidase ku-mitochondria. Lokhu kumuncwa kukhulisa ukukhiqizwa kwamandla eseli (i-ATP), kunciphisa ukucindezeleka okulimazayo kwe-oxidative, futhi kubangele izindlela zokubonisa ezivuselela ama-fibroblast. Lawa maseli abe esekhiqiza i-collagen ne-elastin eningi, okuholela ekuvuseleleni nasekulungiseni isikhumba.
Ngingaqinisekisa kanjani ukuthi idivayisi yokwelapha ngokukhanya okubomvu ekhaya iyasebenza futhi iphephile?
Ukuze uqinisekise idivayisi, beka phambili izindlela ezimbili ezibalulekile: ukuqinisekiswa kobuchwepheshe kanye nemithi yokulawula. Okokuqala, qinisekisa ukuthi ikhipha ukukhanya kuma-wavelength afanele emtholampilo (660nm ngokubomvu, 850nm ngokuseduze kwe-infrared) bese ucela imibiko yelabhorethri ezimele eqinisekisa ukukhanya kwayo (ukukhishwa kwamandla). Okwesibili, funa imvume ye-FDA ukuze uthole inkomba ethile yesikhumba (njengokwelapha induna), hhayi ukubhaliswa kwe-FDA kuphela. Lokhu kuqinisekiswa kusho ukuthi umenzi uthumele idatha yokusebenza ukuze ibuyekezwe. Njalo bheka ukusetshenziswa okuhlosiwe kwedivayisi okuqinisekisiwe futhi ucabangele ukufuna iseluleko kudokotela wesikhumba oqinisekisiwe ebhodini, ikakhulukazi uma unezinkinga zesikhumba ezikhona noma usebenzisa imithi yokwehlisa ukukhanya.
Yiziphi izinkinga noma izingozi eziyinhloko zokuphepha ezihlobene nokwelashwa kokukhanya okubomvu ekhaya?
Ukukhathazeka okuyinhloko kokuphepha ukuzwela kwe-photosensitivity, okungabangelwa yimithi ethile yesistimu (njengeminye imithi elwa namagciwane, imithi yokukhipha isisu, kanye nama-antihistamine) kanye nemithi yokunakekelwa kwesikhumba esetshenziswa endaweni (kufaka phakathi ama-retinoids, ama-AHA, nama-BHA). Ukusebenzisa idivayisi yokukhanya okubomvu ngenkathi usebenzisa lezi zinto kungandisa ingozi yokusabela kabi kwesikhumba. Ezinye izingozi zivela ekushodeni kwesiqondiso sochwepheshe kubasebenzisi basekhaya, kufaka phakathi izinqubo ezingacacile zokuvama kokwelashwa, ubude besikhathi, kanye nomthamo oqongelelekayo. Kubalulekile ukwenza ukuzihlola okuphelele kweziphazamiso nokuqonda ukuthi amadivayisi amaningi abathengi awanazo izifundo eziqinile nezizimele zesikhathi eside eziqhutshwa imishini yobuchwepheshe.
Amadivayisi okwelapha abomvu asezingeni lobuchwepheshe kanye nawasekhaya aqhathaniswa kanjani?
Amadivayisi ochwepheshe nawasekhaya ahluka kakhulu ekulinganisweni, ukuhambisana, ukuqinisekiswa kwezokwelapha, kanye nokuqina. Izinhlelo zobungcweti zakhiwe ukuze zilethe imithamo yokukhanya enembile, ephindaphindwayo ngaphansi kokuqashwa kwezokwelapha ukuze kutholakale ukwelashwa okuqondiswe ezimweni ezithile. Ngokuvamile zinemikhiqizo ephezulu kanye nedatha yezokwelapha eqinile. Amadivayisi abathengi, nakuba elula kakhudlwana, avame ukusebenza ngaphansi kokubhekwa okungaqinile, futhi izimangalo zokumaketha zingase zingasekelwa idatha eqinisekisiwe ngokuzimela. Indlela ehlakaniphile iwabheka njengokuhambisanayo: ukwelashwa kochwepheshe kunikeza ukungenelela okunamandla kakhulu, okunolwazi lokuxilonga, kuyilapho idivayisi yasekhaya ehlolwe kahle enezincazelo ezicacile ingasebenza kahle ekunakekelweni okuqhubekayo kanye nokusekela imigomo yokunakekelwa kwesikhumba yesikhathi eside.

Ukukhanya Okubomvu Kwezilwane
Inkampani Sunglor Technology Co., Ltd
Umuntu othintana naye: Sunglor